Kerala HC seeks experts’ opinions on affordable breast cancer drugs

The Kerala High Court is actively examining the accessibility of affordable breast cancer treatments, seeking expert insights to determine if cheaper, off-patent drugs can serve as viable alternatives to costly patented medications. The court's inquiry stems from concerns that patients might be denied access to essential, life-saving treatment solely because of the prohibitive price of patented alternatives.

To inform its decision, the court has formally requested expert opinions from four distinct institutions. This move underscores the judiciary's commitment to thoroughly understanding the medical and economic implications of drug pricing and patent laws.

The core of the court's examination revolves around the principle of access to healthcare versus the protection of intellectual property. It questions whether patent exclusivity should supersede a patient's right to affordable, life-saving medication, particularly in critical illnesses like breast cancer.